10/19/2022 Categories: Venture Capital Angelini Industries launches Angelini Ventures, with € 300 million commitment
1/4/2021 Categories: Pharma Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
12/22/2020 Categories: Consumer Goods MadreNatura and Angelini Foundation: food adoption kicks off in collaboration with Banco Alimentare Lombardia and Abruzzo
12/1/2020 Sergio Marullo di Condojanni (Angelini Holding) participates in the G20 Business Summit - B20
Angelini Industries
